메뉴 건너뛰기




Volumn 84, Issue 13, 2010, Pages 6505-6514

HIV-1 resistance to CCR5 antagonists associated with highly efficient use of CCR5 and altered tropism on primary CD4+ T cells

Author keywords

[No Author keywords available]

Indexed keywords

APLAVIROC; GLYCOPROTEIN GP 120; GLYCOPROTEIN GP 41; VIRUS ENVELOPE PROTEIN;

EID: 77953305009     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.00374-10     Document Type: Article
Times cited : (55)

References (56)
  • 1
    • 65249151382 scopus 로고    scopus 로고
    • Resistance to CCR5 inhibitors caused by sequence changes in the fusion peptide of HIV-1 gp41
    • Anastassopoulou, C. G., T. J. Ketas, P. J. Klasse, and J. P. Moore. 2009. Resistance to CCR5 inhibitors caused by sequence changes in the fusion peptide of HIV-1 gp41. Proc. Natl. Acad. Sci. U. S. A. 106:5318-5323.
    • (2009) Proc. Natl. Acad. Sci. U. S. A. , vol.106 , pp. 5318-5323
    • Anastassopoulou, C.G.1    Ketas, T.J.2    Klasse, P.J.3    Moore, J.P.4
  • 2
    • 33846574670 scopus 로고    scopus 로고
    • Isolation and characterization of human immunodeficiency virus type 1 resistant to the small-molecule CCR5 antagonist TAK-652
    • Baba, M., H. Miyake, X. Wang, M. Okamoto, and K. Takashima. 2007. Isolation and characterization of human immunodeficiency virus type 1 resistant to the small-molecule CCR5 antagonist TAK-652. Antimicrob. Agents Chemother. 51:707-715.
    • (2007) Antimicrob. Agents Chemother. , vol.51 , pp. 707-715
    • Baba, M.1    Miyake, H.2    Wang, X.3    Okamoto, M.4    Takashima, K.5
  • 4
    • 0036838693 scopus 로고    scopus 로고
    • Identification of conserved and variable structures in the human immunodeficiency virus gp120 glycoprotein of importance for CXCR4 binding
    • Basmaciogullari, S., G. J. Babcock, D. Van Ryk, W. Wojtowicz, and J. Sodroski. 2002. Identification of conserved and variable structures in the human immunodeficiency virus gp120 glycoprotein of importance for CXCR4 binding. J. Virol. 76:10791-10800.
    • (2002) J. Virol. , vol.76 , pp. 10791-10800
    • Basmaciogullari, S.1    Babcock, G.J.2    Van Ryk, D.3    Wojtowicz, W.4    Sodroski, J.5
  • 5
    • 70049098271 scopus 로고    scopus 로고
    • Two HIV-1 variants resistant to small molecule CCR5 inhibitors differ in how they use CCR5 for entry
    • Berro, R., R. W. Sanders, M. Lu, P. J. Klasse, and J. P. Moore. 2009. Two HIV-1 variants resistant to small molecule CCR5 inhibitors differ in how they use CCR5 for entry. PLoS Pathog. 5:e1000548.
    • (2009) PLoS Pathog. , vol.5
    • Berro, R.1    Sanders, R.W.2    Lu, M.3    Klasse, P.J.4    Moore, J.P.5
  • 6
    • 0033989709 scopus 로고    scopus 로고
    • The CXCR4 antagonist AMD3100 efficiently inhibits cell-surface-expressed human immunodeficiency virus type 1 envelope-induced apoptosis
    • Blanco, J., J. Barretina, G. Henson, G. Bridger, E. De Clercq, B. Clotet, and J. A. Este. 2000. The CXCR4 antagonist AMD3100 efficiently inhibits cell-surface-expressed human immunodeficiency virus type 1 envelope-induced apoptosis. Antimicrob. Agents Chemother. 44:51-56.
    • (2000) Antimicrob. Agents Chemother. , vol.44 , pp. 51-56
    • Blanco, J.1    Barretina, J.2    Henson, G.3    Bridger, G.4    De Clercq, E.5    Clotet, B.6    Este, J.A.7
  • 7
    • 0031042433 scopus 로고    scopus 로고
    • The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes
    • Bleul, C. C., L. Wu, J. A. Hoxie, T. A. Springer, and C. R. Mackay. 1997. The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes. Proc. Natl. Acad. Sci. U. S. A. 94:1925-1930.
    • (1997) Proc. Natl. Acad. Sci. U. S. A. , vol.94 , pp. 1925-1930
    • Bleul, C.C.1    Wu, L.2    Hoxie, J.A.3    Springer, T.A.4    Mackay, C.R.5
  • 8
    • 0032577550 scopus 로고    scopus 로고
    • HIV entry and its inhibition
    • Chan, D. C., and P. S. Kim. 1998. HIV entry and its inhibition. Cell 93:681-684.
    • (1998) Cell , vol.93 , pp. 681-684
    • Chan, D.C.1    Kim, P.S.2
  • 9
    • 13844302894 scopus 로고    scopus 로고
    • Structure of an unliganded simian immunodeficiency virus gp120 core
    • Chen, B., E. M. Vogan, H. Gong, J. J. Skehel, D. C. Wiley, and S. C. Harrison. 2005. Structure of an unliganded simian immunodeficiency virus gp120 core. Nature 433:834-841.
    • (2005) Nature , vol.433 , pp. 834-841
    • Chen, B.1    Vogan, E.M.2    Gong, H.3    Skehel, J.J.4    Wiley, D.C.5    Harrison, S.C.6
  • 10
    • 0036333648 scopus 로고    scopus 로고
    • The crown and stem of the V3 loop play distinct roles in human immunodeficiency virus type 1 envelope glycoprotein interactions with the CCR5 coreceptor
    • Cormier, E. G., and T. Dragic. 2002. The crown and stem of the V3 loop play distinct roles in human immunodeficiency virus type 1 envelope glycoprotein interactions with the CCR5 coreceptor. J. Virol. 76:8953-8957.
    • (2002) J. Virol. , vol.76 , pp. 8953-8957
    • Cormier, E.G.1    Dragic, T.2
  • 11
    • 0035000023 scopus 로고    scopus 로고
    • Mapping the determinants of the CCR5 amino-terminal sulfopeptide interaction with soluble human immunodeficiency virus type 1 gp120-CD4 complexes
    • Cormier, E. G., D. N. Tran, L. Yukhayeva, W. C. Olson, and T. Dragic. 2001. Mapping the determinants of the CCR5 amino-terminal sulfopeptide interaction with soluble human immunodeficiency virus type 1 gp120-CD4 complexes. J. Virol. 75:5541-5549.
    • (2001) J. Virol. , vol.75 , pp. 5541-5549
    • Cormier, E.G.1    Tran, D.N.2    Yukhayeva, L.3    Olson, W.C.4    Dragic, T.5
  • 14
    • 0031883554 scopus 로고    scopus 로고
    • A tyrosine-rich region in the N terminus of CCR5 is important for human immunodeficiency virus type 1 entry and mediates an association between gp120 and CCR5
    • Farzan, M., H. Choe, L. Vaca, K. Martin, Y. Sun, E. Desjardins, N. Ruffing, L. Wu, R. Wyatt, N. Gerard, C. Gerard, and J. Sodroski. 1998. A tyrosine-rich region in the N terminus of CCR5 is important for human immunodeficiency virus type 1 entry and mediates an association between gp120 and CCR5. J. Virol. 72:1160-1164. (Pubitemid 28116898)
    • (1998) Journal of Virology , vol.72 , Issue.2 , pp. 1160-1164
    • Farzan, M.1    Choe, H.2    Vaca, L.3    Martin, K.4    Sun, Y.5    Desjardins, E.6    Ruffing, N.7    Wu, L.8    Wyatt, R.9    Gerard, N.10    Gerard, C.11    Sodroski, J.12
  • 16
    • 33748626539 scopus 로고    scopus 로고
    • Differential susceptibility of naive, central memory and effector memory T cells to dendritic cell-mediated HIV-1 transmission
    • Groot, F., T. M. van Capel, J. Schuitemaker, B. Berkhout, and E. C. de Jong. 2006. Differential susceptibility of naive, central memory and effector memory T cells to dendritic cell-mediated HIV-1 transmission. Retrovirology 3:52.
    • (2006) Retrovirology , vol.3 , pp. 52
    • Groot, F.1    Van Capel, T.M.2    Schuitemaker, J.3    Berkhout, B.4    De Jong, E.C.5
  • 19
    • 70350316187 scopus 로고    scopus 로고
    • A quantitative affinity-profiling system that reveals distinct CD4/CCR5 usage patterns among human immunodeficiency virus type 1 and simian immunodeficiency virus strains
    • Johnston, S. H., M. A. Lobritz, S. Nguyen, K. Lassen, S. Delair, F. Posta, Y. J. Bryson, E. J. Arts, T. Chou, and B. Lee. 2009. A quantitative affinity-profiling system that reveals distinct CD4/CCR5 usage patterns among human immunodeficiency virus type 1 and simian immunodeficiency virus strains. J. Virol. 83:11016-11026.
    • (2009) J. Virol. , vol.83 , pp. 11016-11026
    • Johnston, S.H.1    Lobritz, M.A.2    Nguyen, S.3    Lassen, K.4    Delair, S.5    Posta, F.6    Bryson, Y.J.7    Arts, E.J.8    Chou, T.9    Lee, B.10
  • 20
    • 0034608195 scopus 로고    scopus 로고
    • Entry of R5X4 and X4 human immunodeficiency virus type 1 strains is mediated by negatively charged and tyrosine residues in the amino-terminal domain and the second extracellular loop of CXCR4
    • Kajumo, F., D. A. Thompson, Y. Guo, and T. Dragic. 2000. Entry of R5X4 and X4 human immunodeficiency virus type 1 strains is mediated by negatively charged and tyrosine residues in the amino-terminal domain and the second extracellular loop of CXCR4. Virology 271:240-247.
    • (2000) Virology , vol.271 , pp. 240-247
    • Kajumo, F.1    Thompson, D.A.2    Guo, Y.3    Dragic, T.4
  • 21
    • 62949113396 scopus 로고    scopus 로고
    • Virologic failure in therapy-naive subjects on aplaviroc plus lopinavir-ritonavir: Detection of aplaviroc resistance requires clonal analysis of envelope
    • Kitrinos, K. M., H. Amrine-Madsen, D. M. Irlbeck, J. M. Word, and J. F. Demarest. 2009. Virologic failure in therapy-naive subjects on aplaviroc plus lopinavir-ritonavir: detection of aplaviroc resistance requires clonal analysis of envelope. Antimicrob. Agents Chemother. 53:1124-1131.
    • (2009) Antimicrob. Agents Chemother. , vol.53 , pp. 1124-1131
    • Kitrinos, K.M.1    Amrine-Madsen, H.2    Irlbeck, D.M.3    Word, J.M.4    Demarest, J.F.5
  • 23
    • 65549140728 scopus 로고    scopus 로고
    • HIV-1 entry inhibitors: An overview
    • Kuritzkes, D. R. 2009. HIV-1 entry inhibitors: an overview. Curr. Opin. HIV AIDS 4:82-87.
    • (2009) Curr. Opin. HIV AIDS , vol.4 , pp. 82-87
    • Kuritzkes, D.R.1
  • 24
    • 0032543307 scopus 로고    scopus 로고
    • Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody
    • Kwong, P. D., R. Wyatt, J. Robinson, R. W. Sweet, J. Sodroski, and W. A. Hendrickson. 1998. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature 393:648-659.
    • (1998) Nature , vol.393 , pp. 648-659
    • Kwong, P.D.1    Wyatt, R.2    Robinson, J.3    Sweet, R.W.4    Sodroski, J.5    Hendrickson, W.A.6
  • 29
    • 0033609149 scopus 로고    scopus 로고
    • Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages
    • Lee, B., M. Sharron, L. J. Montaner, D. Weissman, and R. W. Doms. 1999. Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages. Proc. Natl. Acad. Sci. U. S. A. 96:5215-5220.
    • (1999) Proc. Natl. Acad. Sci. U. S. A. , vol.96 , pp. 5215-5220
    • Lee, B.1    Sharron, M.2    Montaner, L.J.3    Weissman, D.4    Doms, R.W.5
  • 32
    • 48649101575 scopus 로고    scopus 로고
    • Involvement of the second extracellular loop and transmembrane residues of CCR5 in inhibitor binding and HIV-1 fusion: Insights into the mechanism of allosteric inhibition
    • Maeda, K., D. Das, P. D. Yin, K. Tsuchiya, H. Ogata-Aoki, H. Nakata, R. B. Norman, L. A. Hackney, Y. Takaoka, and H. Mitsuya. 2008. Involvement of the second extracellular loop and transmembrane residues of CCR5 in inhibitor binding and HIV-1 fusion: insights into the mechanism of allosteric inhibition. J. Mol. Biol. 381:956-974.
    • (2008) J. Mol. Biol. , vol.381 , pp. 956-974
    • Maeda, K.1    Das, D.2    Yin, P.D.3    Tsuchiya, K.4    Ogata-Aoki, H.5    Nakata, H.6    Norman, R.B.7    Hackney, L.A.8    Takaoka, Y.9    Mitsuya, H.10
  • 33
    • 20644453529 scopus 로고    scopus 로고
    • Generation and properties of a human immunodeficiency virus type 1 isolate resistant to the small molecule CCR5 inhibitor, SCH-417690 (SCH-D)
    • Marozsan, A. J., S. E. Kuhmann, T. Morgan, C. Herrera, E. Rivera-Troche, S. Xu, B. M. Baroudy, J. Strizki, and J. P. Moore. 2005. Generation and properties of a human immunodeficiency virus type 1 isolate resistant to the small molecule CCR5 inhibitor, SCH-417690 (SCH-D). Virology 338:182-199.
    • (2005) Virology , vol.338 , pp. 182-199
    • Marozsan, A.J.1    Kuhmann, S.E.2    Morgan, T.3    Herrera, C.4    Rivera-Troche, E.5    Xu, S.6    Baroudy, B.M.7    Strizki, J.8    Moore, J.P.9
  • 35
    • 0141814730 scopus 로고    scopus 로고
    • The entry of entry inhibitors: A fusion of science and medicine
    • Moore, J. P., and R. W. Doms. 2003. The entry of entry inhibitors: a fusion of science and medicine. Proc. Natl. Acad. Sci. U. S. A. 100:10598-10602.
    • (2003) Proc. Natl. Acad. Sci. U. S. A. , vol.100 , pp. 10598-10602
    • Moore, J.P.1    Doms, R.W.2
  • 36
    • 70450170953 scopus 로고    scopus 로고
    • Structure-function analysis of human immunodeficiency virus type 1 gp120 amino acid mutations associated with resistance to the CCR5 coreceptor antagonist vicriviroc
    • Ogert, R. A., L. Ba, Y. Hou, C. Buontempo, P. Qiu, J. Duca, N. Murgolo, P. Buontempo, R. Ralston, and J. A. Howe. 2009. Structure-function analysis of human immunodeficiency virus type 1 gp120 amino acid mutations associated with resistance to the CCR5 coreceptor antagonist vicriviroc. J. Virol. 83:12151-12163.
    • (2009) J. Virol. , vol.83 , pp. 12151-12163
    • Ogert, R.A.1    Ba, L.2    Hou, Y.3    Buontempo, C.4    Qiu, P.5    Duca, J.6    Murgolo, N.7    Buontempo, P.8    Ralston, R.9    Howe, J.A.10
  • 37
    • 40849085150 scopus 로고    scopus 로고
    • Mapping resistance to the CCR5 co-receptor antagonist vicriviroc using heterologous chimeric HIV-1 envelope genes reveals key determinants in the C2-V5 domain of gp120
    • Ogert, R. A., L. Wojcik, C. Buontempo, L. Ba, P. Buontempo, R. Ralston, J. Strizki, and J. A. Howe. 2008. Mapping resistance to the CCR5 co-receptor antagonist vicriviroc using heterologous chimeric HIV-1 envelope genes reveals key determinants in the C2-V5 domain of gp120. Virology 373:387-399.
    • (2008) Virology , vol.373 , pp. 387-399
    • Ogert, R.A.1    Wojcik, L.2    Buontempo, C.3    Ba, L.4    Buontempo, P.5    Ralston, R.6    Strizki, J.7    Howe, J.A.8
  • 39
    • 34047271098 scopus 로고    scopus 로고
    • HIV-1 clones resistant to a small molecule CCR5 inhibitor use the inhibitor-bound form of CCR5 for entry
    • Pugach, P., A. J. Marozsan, T. J. Ketas, E. L. Landes, J. P. Moore, and S. E. Kuhmann. 2007. HIV-1 clones resistant to a small molecule CCR5 inhibitor use the inhibitor-bound form of CCR5 for entry. Virology 361:212-228.
    • (2007) Virology , vol.361 , pp. 212-228
    • Pugach, P.1    Marozsan, A.J.2    Ketas, T.J.3    Landes, E.L.4    Moore, J.P.5    Kuhmann, S.E.6
  • 40
    • 64849083122 scopus 로고    scopus 로고
    • Inefficient entry of vicriviroc-resistant HIV-1 via the inhibitor-CCR5 complex at low cell surface CCR5 densities
    • Pugach, P., N. Ray, P. J. Klasse, T. J. Ketas, E. Michael, R. W. Doms, B. Lee, and J. P. Moore. 2009. Inefficient entry of vicriviroc-resistant HIV-1 via the inhibitor-CCR5 complex at low cell surface CCR5 densities. Virology 387:296-302.
    • (2009) Virology , vol.387 , pp. 296-302
    • Pugach, P.1    Ray, N.2    Klasse, P.J.3    Ketas, T.J.4    Michael, E.5    Doms, R.W.6    Lee, B.7    Moore, J.P.8
  • 41
    • 0031900659 scopus 로고    scopus 로고
    • Alanine substitutions of polar and nonpolar residues in the amino-terminal domain of CCR5 differently impair entry of macrophage- And dualtropic isolates of human immunodeficiency virus type 1
    • Rabut, G. E., J. A. Konner, F. Kajumo, J. P. Moore, and T. Dragic. 1998. Alanine substitutions of polar and nonpolar residues in the amino-terminal domain of CCR5 differently impair entry of macrophage- and dualtropic isolates of human immunodeficiency virus type 1. J. Virol. 72:3464-3468.
    • (1998) J. Virol. , vol.72 , pp. 3464-3468
    • Rabut, G.E.1    Konner, J.A.2    Kajumo, F.3    Moore, J.P.4    Dragic, T.5
  • 42
    • 0034690683 scopus 로고    scopus 로고
    • Fine definition of a conserved CCR5-binding region on the human immunodeficiency virus type 1 glycoprotein 120
    • Rizzuto, C., and J. Sodroski. 2000. Fine definition of a conserved CCR5-binding region on the human immunodeficiency virus type 1 glycoprotein 120. AIDS Res. Hum. Retroviruses 16:741-749.
    • (2000) AIDS Res. Hum. Retroviruses , vol.16 , pp. 741-749
    • Rizzuto, C.1    Sodroski, J.2
  • 45
    • 0033554726 scopus 로고    scopus 로고
    • Two subsets of memory T lymphocytes with distinct homing potentials and effector functions
    • Sallusto, F., D. Lenig, R. Forster, M. Lipp, and A. Lanzavecchia. 1999. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401:708-712. (Pubitemid 129515761)
    • (1999) Nature , vol.401 , Issue.6754 , pp. 708-712
    • Sallusto, F.1    Lenig, D.2    Forster, R.3    Lipp, M.4    Lanzavecchia, A.5
  • 49
    • 73549092165 scopus 로고    scopus 로고
    • Entry inhibitors in the treatment of HIV-1 infection
    • Tilton, J. C., and R. W. Doms. 2010. Entry inhibitors in the treatment of HIV-1 infection. Antiviral Res. 85:91-100.
    • (2010) Antiviral Res. , vol.85 , pp. 91-100
    • Tilton, J.C.1    Doms, R.W.2
  • 54
    • 15744391870 scopus 로고    scopus 로고
    • The CCR5 receptor-based mechanism of action of 873140, a potent allosteric noncompetitive HIV entry inhibitor
    • Watson, C., S. Jenkinson, W. Kazmierski, and T. Kenakin. 2005. The CCR5 receptor-based mechanism of action of 873140, a potent allosteric noncompetitive HIV entry inhibitor. Mol. Pharmacol. 67:1268-1282.
    • (2005) Mol. Pharmacol. , vol.67 , pp. 1268-1282
    • Watson, C.1    Jenkinson, S.2    Kazmierski, W.3    Kenakin, T.4
  • 55
    • 33646443202 scopus 로고    scopus 로고
    • Emergence of CXCR4-using human immunodeficiency virus type 1 (HIV-1) variants in a minority of HIV-1-infected patients following treatment with the CCR5 antagonist maraviroc is from a pretreatment CXCR4-using virus reservoir
    • Westby, M., M. Lewis, J. Whitcomb, M. Youle, A. L. Pozniak, I. T. James, T. M. Jenkins, M. Perros, and E. van der Ryst. 2006. Emergence of CXCR4-using human immunodeficiency virus type 1 (HIV-1) variants in a minority of HIV-1-infected patients following treatment with the CCR5 antagonist maraviroc is from a pretreatment CXCR4-using virus reservoir. J. Virol. 80:4909-4920.
    • (2006) J. Virol. , vol.80 , pp. 4909-4920
    • Westby, M.1    Lewis, M.2    Whitcomb, J.3    Youle, M.4    Pozniak, A.L.5    James, I.T.6    Jenkins, T.M.7    Perros, M.8    Van Der Ryst, E.9
  • 56
    • 33847237614 scopus 로고    scopus 로고
    • Reduced maximal inhibition in phenotypic susceptibility assays indicates that viral strains resistant to the CCR5 antagonist maraviroc utilize inhibitor-bound receptor for entry
    • Westby, M., C. Smith-Burchnell, J. Mori, M. Lewis, M. Mosley, M. Stockdale, P. Dorr, G. Ciaramella, and M. Perros. 2007. Reduced maximal inhibition in phenotypic susceptibility assays indicates that viral strains resistant to the CCR5 antagonist maraviroc utilize inhibitor-bound receptor for entry. J. Virol. 81:2359-2371.
    • (2007) J. Virol. , vol.81 , pp. 2359-2371
    • Westby, M.1    Smith-Burchnell, C.2    Mori, J.3    Lewis, M.4    Mosley, M.5    Stockdale, M.6    Dorr, P.7    Ciaramella, G.8    Perros, M.9


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.